Form 4: Bicycle Therapeutics Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael Skynner, Chief Technology Officer of Bicycle Therapeutics plc, sold 955 ordinary shares to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- Michael Skynner, the Chief Technology Officer of Bicycle Therapeutics plc, sold 955 ordinary shares on April 3, 2024.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $23.81, with individual transactions ranging from $23.75 to $24.05.
- Following the transaction, Skynner still beneficially owns 94,884 ordinary shares.
Sentiment
Score: 6
Explanation: The document reflects a neutral sentiment as it reports a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any positive or negative outlook for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and employees. This transaction is a routine event and doesn't necessarily indicate a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of shares has a minimal impact on shareholders as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/03/2024 | Date of the share sale transaction. |
| 04/05/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.